The internet platform for animal-free research

Invitro+Jobs

The internet platform
for animal-free research

  • Research groups and scientific networking
  • Platform for jobs, theses and internships
  • News relating to in vitro and in silico research
  • Information about research funding

Latest News from the InVitro-World

  • Amyloid fibrils: Different than thought
    For the first time, a German-American team of scientists has succeeded in isolating and investigating beta-amyloid fibrils from the human brain. These protein fibers are suspected of causing Alzheimer's disease and cerebral amyloid angiopathy.
    Written on Thursday, 14 November 2019 12:20 Read more...
  • Tax support for research by companies
    In its second and third readings, the German Parliament (Bundestag) passed the "Law on the Introduction of Tax Research Support".
    Written on Wednesday, 13 November 2019 12:47 Read more...
  • Organoids against colorectal cancer metastases
    A Dutch team of scientists has used organoids to successfully predict the efficacy of chemotherapy against metastatic colorectal cancer.
    Written on Monday, 04 November 2019 12:58 Read more...
  • „Sometimes an ambitious goal is what is needed to create significant change“
    The Institute for In Vitro Sciences (IIVS), headquartered in Gaithersburg, Maryland, is a non-profit research and test laboratory dedicated to the worldwide further development of animal-free in vitro methods. InVitro+Jobs spoke with Dr. Erin Hill, co-founder, and president of the IIVS, about the Environmental Protection Agency's goal to completely phase out mammalian toxicity testing by 2035.
    Written on Wednesday, 30 October 2019 12:02 Read more...
  • Prime Editing to more precise genetic modifications
    Researchers from the Broad Institute of Harvard and MIT at Cambridge have developed a new gene-editing technique that modifies the genetic code more precisely than the CRISPR/Cas9 currently in use. The procedure is called Prime Editing and is expected to be promising for the future therapy of hereditary diseases.
    Written on Tuesday, 29 October 2019 15:33 Read more...
  • SEAC expert: EU citizens and industry expect "big reduction" of mandatory animal testing
    Dr. Julia Fentem is head of the Unilever Safety and Environment Centre (SEAC). She spoke with EURACTIV.com on "Building trust for the use of 3Rs" on 29 October before the annual European Partnership for Alternative Approaches (EPAA) conference.
    Written on Tuesday, 29 October 2019 15:06 Read more...